Risk and severity of psoriasis vulgaris in relation to angiotensin II type 1 receptor gene polymorphism and metabolic syndrome

References

• Fotiadou C, Lazaridou E, loannides D. Management of psoriasis in adolescence. Adolesc Health Med Ther. 2014;5:25. doi:10.2147/AHMT.S3667224729738
   PubMedGoogle Scholar
• Sales R, Torres T. Psoriasis and metabolic syndrome. Acta Dermatovenerol Croat. 2014;22(3):169.25230056
   PubMed Web of Science ®Google Scholar
• Wolska A, Michalsk-Jakabus M, Pietrzak A, et al. Metabolic syndrome in patients with psoriasis. Pol Merkur Lekarski. 2014;36(213):215–219.24779224
   PubMedGoogle Scholar
• Grundy SM, Cleeman JI, Daniel SR, et al. Diagnosis and management of the metabolic syndrome : an American heart association national heart lung and blood institute scientific statement. circulation. 2005;112:2735–2752. doi:10.1161/CIRCULATIONAHA.105.16940416157765
   PubMed Web of Science ®Google Scholar
• Scholzen TE, Stander S, Riemann H, et al. Modulation of cutaneous inflammation by angiotensin-converting enzyme. J Immunol. 2003;170:3866–3873. doi:10.4049/jimmunol.170.7.386612646655
   PubMed Web of Science ®Google Scholar
• Rahimi Z, Rahimi Z, Aghaei A, et al. AT2R –1332 G: a polymorphism and its interaction with AT1R 1166 A:C, ACE I/D and MMP–9 –1562 C: T polymorphisms: risk factors for susceptibility to preeclampsia. Gene. 2014;538:176–181. doi:10.1016/j.gene.2013.12.01324440243
   PubMed Web of Science ®Google Scholar
• Yang K, Zhang F, Li F, et al. Angiotensin converting enzyme insertion/deletion polymorphism and susceptibility to psoriasis in a Chinese population. J Renin Angiotensin Aldosterone Syst. 2014;15:39–43. doi:10.1177/147032031349443323846034
   PubMed Web of Science ®Google Scholar
• Kikuya M, Sugimoto K, Katsuya T, et al. A/C1166 gene polymorphism of the Angiotensin II type 1 receptor (AT1) and ambulatory blood pressure: the Ohasama study. Hypertens. 2003;26:141–145.
   Web of Science ®Google Scholar
• Artiss JD, Zak B. Measurement of cholesterol concentration In: Rifai N, Warnick GR and Dominiczak MH, editor. Handbook of Lipoprotein Testing. Washington: AACC Press; 1997:99–114.
   Google Scholar
• Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem. 1969;6:24–27. doi:10.1177/000456326900600108
   Google Scholar
• Soldatovic I, Vukovic R, Culafic D, et al. siMS score : simple method for quantifying metabolic syndrome. PLOS ONE 2016;11(1):e0146143. doi:10.1371/journal.pone.0146143
   Google Scholar
• Trowsdale J. Genetic structure and function in MHC. Trends Genet. 1993;9:117–121. doi:10.1016/0168-9525(93)90205-V8516845
   PubMed Web of Science ®Google Scholar
• Wu Z, chen Z, Logan OM, et al. Transparent, conductive, carbon nanotube films. Science. 2004;305(5688):1273–1276. doi:10.1126/science.110124315333836
   PubMed Web of Science ®Google Scholar
• Gelfand JM, Yeung H. Metabolic syndrome in patients with psoriatic disease. J Rheumatol Suppl. 2012;89:24–28. doi:10.3899/jrheum.12023722751586
   PubMedGoogle Scholar
• Gisondi P, Ferrazzi A, Girolomoni G. Metabolic comorbidities and psoriasis. Acta Dermatovenerol Croat. 2010;18(4):297–304.21251450
   PubMed Web of Science ®Google Scholar
• Zindanc I, Albayrak O, Kavala M, et al. Prevalence of metabolic syndrome in patients with psoriasis. Sci World J. 2012;312463:1-5.
   Google Scholar
• Sommer DM, Jenisch S, Suchan M, et al. Increased prevalence of metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res. 2006;298(7):321–328. doi:10.1007/s00403-006-0703-z17021763
   PubMed Web of Science ®Google Scholar
• Nisa N, Qazi MA. Prevalence of metabolic syndrome in patients with psoriasis. Indian J Dermatol Venereol Leprol. 2010;76(6):662–665. doi:10.4103/0378-6323.7246221079309
   PubMed Web of Science ®Google Scholar
• Malbrias L, Granath F, Hamsten A, et al. Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol. 2006;54:614–621. doi:10.1016/j.jaad.2005.11.107916546581
   PubMed Web of Science ®Google Scholar
• Banerjee S, More U, Tilak MA, et al. Lipid alterations in psoriasis. Indian J Basic Appl Med Res. 2014;3(2):350–357.
   Google Scholar
• Uyanik BS, Ari Z, Onur E, et al. Serum lipids and apolipoproteins in patients with psoriasis. Clin Chem Lab Med. 2002;40:65–68. doi:10.1515/CCLM.2002.01311916273
   PubMed Web of Science ®Google Scholar
• Ahmed AA. Serum lipid profile in Psoriasis: a controlled study. Tikrit Med J. 2011;17(1):38–42.
   Google Scholar
• Akhyani M, Ehsani A, Robati R, et al. The lipid profile in psoriasis: a controlled study. J Eur Acad Dermatol Venereol. 2007;21:1330–1332. doi:10.1111/jdv.2007.21.issue-1017958837
   PubMed Web of Science ®Google Scholar
• Baja DR, Mahesar SM, Devrajani BR, et al. Lipid profile in patients with psoriasis presenting at Liaquat University Hospital Hyderabad. J Pak Med Assoc. 2009;59(8):512–515.19757693
   PubMedGoogle Scholar
• Toker A, Kadi M, Yildirim AK, et al. Serum lipid profile paraoxonase and arylesterase activities in psoriasis. Cell Biochem Funct. 2009;27(3):176–180. doi:10.1002/cbf.155319330810
   PubMed Web of Science ®Google Scholar
• Reynoso DC, Martinez BR, Bustos SR, et al. Lipid profile, insulin secretion, and insulin sensitivity in psoriasis. J Am Acad Dermatol. 2003;48:882–885. doi:10.1067/mjd.2003.44612789179
   PubMed Web of Science ®Google Scholar
• Farshchian M, Zamanian A, Farshichian M, et al. Serum lipid levels in Iranian patients with psoriasis. J Eur Assoc Deramatol Venereol. 2007;21:802–805. doi:10.1111/j.1468-3083.2006.02099.x
   Web of Science ®Google Scholar
• Khungar N, Gupta D, Ramesh V. Is psoriasis a new cutaneous marker for metabolic syndrome? A study in indian patients. Indian J Dermatol. 2013;58(4):313–314. doi:10.4103/0019-5154.11395823919006
   PubMedGoogle Scholar
• Pereira R, Amladi S, Varthakavi P. A study of the prevalence of diabetes, insulin resistance, lipid abnormalities, and cardiovascular risk factors in patients with chronic plaque psoriasis. Indian J Dermatol. 2011;56(5):520–526. doi:10.4103/0019-5154.8714422121269
   PubMedGoogle Scholar
• Madanagobalane S, Anandan S. Prevalence of metabolic syndrome in south indian patients with psoriasis vulgaris and the relation between disease severity and metabolic syndrome: a hospital based case control study. Indian J Dermatol. 2012;57(5):353–357. doi:10.4103/0019-5154.9266923112353
   PubMedGoogle Scholar
• Johann E, Gudjonsson T, Elder N, et al. Fitzpatrick’s Dermatology in General Medicine. 7th Vol. 1 McGraw-Hill; 2008:169–193.
   Google Scholar
• Kadam DP, Suryakar AN, Ankush RD, et al. Role of oxidative stress in various stages of psoriasis. Indian J Clin Biochem. 2010;25:388‐392. doi:10.1007/s12291-010-0043-9
   Google Scholar
• Mohammadi Y, Vaisi-Raygani A, Shakiba E, et al. Angiotensin II type 1 receptor A1166 C (rs5186) gene polymorphism increased risk and severity of psoriasis, contribution to oxidative stress, antioxidant statues, lipid peroxidation and correlation with vascular adhesion protein 1, preliminary report. J Eur Acad Dermatol Venereol. 2016;30:1395–1397. doi:10.1111/jdv.1365226395033
   PubMed Web of Science ®Google Scholar
• Abdollahi MR, Gaunt TR, Syddall HE, et al. Angiotensin II type I receptor gene polymorphism: anthropometric and metabolic syndrome traits. J Med Genet. 2005;42(5):396–401. doi:10.1136/jmg.2004.02448915863668
   PubMed Web of Science ®Google Scholar
• Palatini P, Ceolotto G, Dorigatti F, et al. Angiotensin II type 1 receptor gene polymorphism predicts development of hypertension and metabolic syndrome. Am J Hypertens. 2009;22(2):208–214. doi:10.1038/ajh.2008.31919023273
   PubMed Web of Science ®Google Scholar
• Tanhapour M, Falahi B, Vaisi‐Raygani A, et al. Angiotensin‐converting enzyme insertion/deletion (rs106180) and angiotensin type 1 receptor A1166C (rs106165) genotypes and psoriasis: correlation with cellular immunity, lipid profile, and oxidative stress markers. J Cell Biochem. 2018;10:1‐7.
   Google Scholar